Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Infect Disord Drug Targets ; 22(2): e170322191922, 2022.
Article in English | MEDLINE | ID: covidwho-1110180

ABSTRACT

Coronavirus disease 2019 (COVID-19) is a serious viral disease caused by SARS-CoV-2, associated with high morbidity and mortality, and represents a significant public health crisis worldwide. Despite recent efforts for developing novel antiviral agents, no specific drugs are approved for the management and treatment of COVID-19. The immune responses to viral infection followed by cytokine storm and acute respiratory distress syndrome are serious issues that may cause death in patients with severe COVID-19. Therefore, developing a novel therapeutic strategy for the management of COVID-19 is urgently needed to control the virus spread and to improve the patient survival rate and clinical outcomes. In this mini-review, we summarize the symptoms, pathogenesis, and therapeutic approaches currently being used to manage the spread of SARS-CoV-2.


Subject(s)
COVID-19 Drug Treatment , COVID-19 , Respiratory Distress Syndrome , Antiviral Agents/therapeutic use , COVID-19/diagnosis , Humans , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL